Rubicon Organics Stock Price, News & Analysis

Rubicon Organics (OTCQX: ROMJF) announced it won seven awards at the 2025 KIND Awards on November 17, 2025, across its House of Brands.

Key wins include Simply Bare Organic as Craft Brand of the Year (second consecutive year); BC Organic Pink Drip named Budtender Choice: Weed of the Year and Flower of the Year; 1964 Supply Co. Brand of the Year and Vape of the Year for Blue Dream FSE Resin Vape (both second consecutive years); Comatose FSE Resin AIO Vape as Best New Product Launch; and Wildflower as Wellness Brand of the Year (second consecutive year).

Management noted awards reflect budtender endorsement and cited growing premium product availability from the newly licensed Cascadia facility.

Rubicon Organics (OTCQX: ROMJF) reported Q3 2025 net revenue of $15.6M (+16% YoY) and 2025 YTD net revenue of $43.0M (+25% YoY). Adjusted EBITDA was $1.7M in Q3 and $3.8M YTD. The company obtained a Health Canada license for the Cascadia Facility, expecting revenue from Cascadia in H1 2026 and a >40% increase in production capacity. Inventory rose to $16.75M and cash totaled $6.69M at Sept 30, 2025. The company completed a $4.0M financing and secured a $3.0M loan plus $1.0M LOC in Nov 2025.

Rubicon Organics (OTCQX: ROMJF) appointed Glen Ibbott as Chief Financial Officer and Corporate Secretary, effective after a six-month interim period, announced Nov 13, 2025. Mr. Ibbott has over 25 years of finance leadership in life sciences and cannabis, served as CFO of Aurora Cannabis from 2017–2024, and held senior roles including at QLT where he was involved in a $500 million merger.

The company said his prior six months as interim CFO demonstrated strategic impact while he holds a CPA and MBAs from Cornell and Queen’s. The appointment signals continuity in financial leadership as Rubicon scales premium cannabis operations and expands markets.

Rubicon Organics (OTCQX: ROMJF / TSXV: ROMJ) announced it secured $4,000,000 in additional credit agreements with Community Savings Credit Union on Nov 10, 2025. The debt package includes a $3.0M capital loan (5-year term, 10-year amortization, 6.79% annual interest) and a $1.0M line of credit (CSCU Basic Lending Rate + 5.50% monthly). The Credit Agreements are secured against the Cascadia Facility and are expected to be finalized within the next month. The company said proceeds will fund margin-accretive projects at its Pacifica and Cascadia facilities to support strategic growth while preserving balance sheet flexibility.

Rubicon Organics (OTCQX: ROMJF; TSXV: ROMJ) will release Q3 2025 financial results for the three and nine months ended September 30, 2025 after market close on Wednesday, November 12, 2025. The company will host a conference call to discuss results on Thursday, November 13, 2025 at 7:00 AM PT / 10:00 AM ET. Call details: Conference ID 89693, local dial-in +1 (289) 514 5100, toll-free North America +1 (800) 717 1738, and a webcast available via Rubicon Organics Q3 2025 Earnings Call registration.

Rubicon Organics (OTCQX: ROMJF) published its fifth annual ESG Report covering January 1 to December 31, 2024. The report highlights five-year progress since 2020 across business, governance, environment, and social metrics.

Key figures: net revenue rose 410% from $9.4M in 2020 to $49M in 2024; energy use increased 17% and water use increased 58% over the same period. Governance disclosures include board oversight and CEO pay ratio. Social metrics show 80% employee pride and 86% engagement survey participation (94% for temporary foreign workers).

Rubicon Organics (OTCQX: ROMJF) announced that its Cascadia facility in Hope, British Columbia, received a Health Canada licence to cultivate, process, and store cannabis.

The purpose-built, 47,500 sq ft indoor site adds 4,500 kg of annual production capacity, a 40% incremental increase that brings Rubicon's total premium annual capacity to 15,500 kg. Operations are underway and the company expects first revenue in H1 2026. Management said the facility uses advanced cultivation technologies and will support domestic demand and international market opportunities. Rubicon also renamed its Delta facility to Pacifica.

Rubicon Organics (OTCQX: ROMJF), Canada's leading premium licensed producer of organic certified cannabis products, has announced its participation in two upcoming investor events. The company will present at Small Cap Discoveries in Vancouver (September 29-30) and the Planet MicroCap Showcase in Toronto (October 21-23).

Additionally, Rubicon has engaged Atrium Research Corporation for research services at $3,500 monthly for 12 months starting October 1st, 2025, pending TSXV approval.

Rubicon Organics (OTCQX: ROMJF), Canada's leading premium organic cannabis producer, reported strong Q2 2025 financial results with net revenue of $15.0 million, up 24% year-over-year. The company achieved Adjusted EBITDA of $1.4 million and positive operating cash flow of $0.8 million.

Key developments include the acquisition of the Hope Facility, increasing production capacity by 40% to 15,500 kg annually, and completion of a $4.5 million private placement. The company expanded its product portfolio with the launch of 1964 Premium All-in-One Resin Vapes and maintained strong market share positions: 5.2% in premium flower/pre-rolls, 15.1% in resin vapes, and 26.2% in premium edibles.

For 2025, Rubicon expects growth in both revenue and Adjusted EBITDA, despite anticipated one-time costs of $1-2 million related to the Hope Facility start-up. The company is also exploring international market opportunities while maintaining focus on Canadian market leadership.